SARS-CoV-2 Safety Study for the Treatment of COVID-19

NCT06489860 | Withdrawn Phase 2 DMC

• 1 other identifier: DHACoffee
• Study Type: interventional
• Target: N/A
• Locations: 0 countries
• Sites: N/A

Brief Summary

SARS-CoV-2 produced strong pluripotent stem cells and brain cells to protect Telomere chromosomes to maintain Acid Deoxyribonucleic (ADN) Molecules.

Conditions

SARS-CoV-2

Outcome Measures

Primary Outcomes (1)

• SARS-CoV-2

  1. Parameters: Humidification, Unit: %, Result: 4.40, Test Method: ISO 7932: 2004. 2. Cadmium (Cd), mg/Kg, 0.1, CASE.TN.0018 (Ref. AOAC 999.11). 3. Hydrargyrum (Hg), mg/Kg, 0.01, CASE.TN.0141 (Ref . EPA Method 7473). 4. Plumbum (Pb), mg/liter, 0.001, SMEWW3030E 2017: 31258: 2017. 5. Cadmium (Cd), mg/liter, 0.0001, SMEWW3030E 2017: 31258: 2017. . 6. Arsen (As), mg/liter, 0.001, SMEWW3030E 2017: 31258: 2017. 7. Hydrargyrum (Hg), mg/liter, 0.0001, SMEWW3030E 2017: 31258: 2017. 8. Clostridium perfringents, CFU/g, \< 10, ISO 7937:2004. 9. Coliforms, CFU/g, \< 10, ISO 4832:2006 (\*). 10. Escherichia coli, CFU/g, \< 10, ISO 7937:2006. 11. Salmonella, /25g, Not detected, ISO 7937:2007. 12. Staphylococcus aureus, CFU/g, \< 10, ISO 7937:2008. 13. Total Yeasts molds, CFU/g, \< 10, ISO 7937:2009. 14. Total Aerobic Microbial, CFU/g, 1.0 x 100, ISO 7937:2010. 15. Vibrio parahaemolyticuc, /25g, Not detected, ISO 7937:2011. .

  From September to October, 2024

Study Arms (1)

SARS-CoV-2 Safety Study for the Treatment of COVID-19

EXPERIMENTAL

Directions: For adults and for Children 1-12 years old. Indication:SARS-CoV-2 Ingredients: Organic Rice 95% and Honey 5% Powder (whole) 1g. Mix one packet with 6.8 fl oz (200 ml) of hot water (220ºF/100ºC) about three minutes until dissolved. Participants: Use 4 to 5 packets, use one pack each time after two hours. Humidification: \<5% Dosage Form: Powder form Dosage Strength: 1.0 G/ 1 Unit, use one pack of 1 g for each time Use within two years from the manufacturing date. Storage normal conditions in dry, cool and temperature from 15 °C to 32 °C Store in a dry environment (75% humidity).

Drug: HIV; Drug: Malignant Neoplasms Safety Study for the Treatment of Neoplasms

Interventions

HIV DRUG

Directions: For adults and for Children 1-12 years old. Indication: HIV Ingredient: Organic Rice 93% and Honey 7% Powder (whole) 1g. Masking: None (Open Label) Mix one packet with 6.8 fl oz (200 ml) of hot water (220ºF/100ºC) about three minutes until dissolved. Participants: Use 4 to 5 packets, use one pack each time after two hours. Humidification: \<5% Dosage Form: Powder form Dosage Strength: 1.0 G/ 1 Unit, use one pack of 1 g for each time Use within two years from the manufacturing date

Also known as: HIV Safety Study for the Treatment of Anti-AIDS Drug

SARS-CoV-2 Safety Study for the Treatment of COVID-19

Malignant Neoplasms Safety Study for the Treatment of Neoplasms DRUG

Directions: For adults and for Children 1-12 years old. Indication: Malignant Neoplasms . Ingredient: Organic Rice 92% and Honey 8% Powder (whole) 1g. Mix one packet with 6.8 fl oz (200 ml) of hot water (220ºF/100ºC) about three minutes until dissolved. Participants: Use 4 to 5 packets, use one pack each time after two hours. Humidification: \<5% Dosage Form: Powder form Dosage Strength: 1.0 G/ 1 Unit, use one pack of 1 g for each time Use within two years from the manufacturing date.

Also known as: Malignant Neoplasms

SARS-CoV-2 Safety Study for the Treatment of COVID-19

Eligibility Criteria

• Age: 1 Year - 130 Years
• Gender Eligibility Details: Directions: For adults and for Children 1-12 years old.
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• SARS-CoV-2

Sponsors & Collaborators

• DHA Coffee Co., Ltd: lead

Related Publications (1)

• Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov results database--update and key issues. N Engl J Med. 2011 Mar 3;364(9):852-60. doi: 10.1056/NEJMsa1012065.

  PMID: 21366476 RESULT

Related Links

• This Website was pause hosting website

Study Officials

• PHUOC T DO

  DHA Coffee Co., Ltd

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: phase 2
• Allocation: NA
• Masking: NONE
• Masking Details: Directions: For adults and for Children 1-12 years old. Indication: SARS-CoV-2 Ingredient: Organic Rice 95% and Honey 5% Powder (whole) 1g. Mix one packet with 6.8 fl oz (200 ml) of hot water (220ºF/100ºC) about three minutes until dissolved. Participants: Use 4 to 5 packets, use one pack each time after two hours. Humidification: \<5% Dosage Form: Powder form Dosage Strength: 1.0 G/ 1 Unit, use one pack of 1 g for each time Use within two years from the manufacturing date. Storage normal conditions in dry, cool and temperature from 15 °C to 32 °C Store in a dry environment (75% humidity).
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: DHA Coffee Co., Ltd

Model Details: SARS-CoV-2. Directions: For adults and for Children 1-12 years old. Indication: SARS-CoV-2. Ingredient: Organic Rice 95% and Honey 5% Powder (whole) 1g.

Study Record Dates

• First Submitted: March 5, 2024
• First Posted: July 8, 2024
• Study Start: January 28, 2025
• Primary Completion: January 30, 2025
• Study Completion: February 4, 2025
• Last Updated: September 4, 2025

Record last verified: 2025-08

Data Sharing

• IPD Sharing: Will not share